- Global Pharma News & Resources

Cygnal Therapeutics

Research & Development

Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. We are creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.